Peptides and compositions
US4816441A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | Nov 14, 1986 |
| Grant date | Mar 28, 1989 |
| Priority date | — |
| Expiry date | Nov 14, 2006 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Peptides of the formula R.sup.1 -His-Asp-Glu-Ala-R wherein R.sup.1 is Ala-Gln, and R is a polypeptide residue with up to 50 amino acid residues, and wherein one, more or all of the amino acid residues in R.sup.1 and/or R independently may be omitted, can be used to augment cell mediated cytotoxicity and thereby to treat cancers and viral infections. These peptides may be prepared by proteolytic digestion of Staphylococcus aureus protein A, as well as by protein synthesis, recombinant DNA methods or any other methods known in the art.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.